The clinical significance of KL-6 changes is further corroborated by the study conducted by Choi et al., which reported that changes in KL-6 levels could serve as significant factors in the clinical course of patients with AE-IPF [34]. The gene discussed is MUC1; the disease is idiopathic pulmonary fibrosis.